相似文献
1
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.
J Clin Microbiol. 1997 Jan;35(1):270-2. doi: 10.1128/jcm.35.1.270-272.1997.
2
Candida and candidaemia. Susceptibility and epidemiology.
Dan Med J. 2013 Nov;60(11):B4698.
3
Evaluation of a colorimetric method for detecting amphotericin B-resistant Candida isolates.
Diagn Microbiol Infect Dis. 1998 Jul;31(3):417-24. doi: 10.1016/s0732-8893(98)00031-5.
4
Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest.
J Clin Microbiol. 2001 Jan;39(1):339-42. doi: 10.1128/JCM.39.1.339-342.2001.
5
Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates.
J Clin Microbiol. 2004 May;42(5):2252-4. doi: 10.1128/JCM.42.5.2252-2254.2004.
6
7
8
Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates.
J Antimicrob Chemother. 2001 May;47(5):521-6. doi: 10.1093/jac/47.5.521.
9
[Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
Mikrobiyol Bul. 2008 Apr;42(2):293-300.
10
Evaluation of semisolid agar screening tests for determining fluconazole and amphotericin B susceptibilities of Candida strains by using three different media.
J Chemother. 2003 Feb;15(1):37-42. doi: 10.1179/joc.2003.15.1.37.
引用本文的文献
1
Evaluation of the MIC test strips for antifungal susceptibility testing of () using a representative international collection of isolates.
J Clin Microbiol. 2025 Aug 13;63(8):e0039925. doi: 10.1128/jcm.00399-25. Epub 2025 Jul 3.
2
Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
Antimicrob Agents Chemother. 2022 May 17;66(5):e0172521. doi: 10.1128/aac.01725-21. Epub 2022 Apr 12.
3
Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI).
Braz J Microbiol. 2020 Dec;51(4):1791-1800. doi: 10.1007/s42770-020-00354-6. Epub 2020 Aug 5.
4
Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.
J Fungi (Basel). 2019 Nov 22;5(4):108. doi: 10.3390/jof5040108.
5
Relationship between susceptibility of Candida spp. isolates to amphotericin B and death or survival of patients with candidemia episodes.
Mycopathologia. 2009 Feb;167(2):65-71. doi: 10.1007/s11046-008-9159-3. Epub 2008 Sep 26.
6
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
J Clin Microbiol. 2007 Mar;45(3):858-64. doi: 10.1128/JCM.01900-06. Epub 2007 Jan 10.
7
Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
J Clin Microbiol. 2006 Oct;44(10):3616-22. doi: 10.1128/JCM.01187-06. Epub 2006 Aug 30.
8
Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.
Antimicrob Agents Chemother. 2006 Apr;50(4):1287-92. doi: 10.1128/AAC.50.4.1287-1292.2006.
9
Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates.
J Clin Microbiol. 2004 May;42(5):2252-4. doi: 10.1128/JCM.42.5.2252-2254.2004.
10
Proficiency testing program for clinical laboratories performing antifungal susceptibility testing of pathogenic yeast species.
J Clin Microbiol. 2003 Mar;41(3):1143-6. doi: 10.1128/JCM.41.3.1143-1146.2003.
本文引用的文献
1
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.
Antimicrob Agents Chemother. 1995 Nov;39(11):2520-2. doi: 10.1128/AAC.39.11.2520.
2
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
J Infect Dis. 1994 Aug;170(2):384-9. doi: 10.1093/infdis/170.2.384.
3
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
N Engl J Med. 1994 Nov 17;331(20):1325-30. doi: 10.1056/NEJM199411173312001.
4
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
J Clin Microbiol. 1994 Jul;32(7):1650-3. doi: 10.1128/jcm.32.7.1650-1653.1994.
5
Detection of amphotericin B-resistant Candida isolates in a broth-based system.
Antimicrob Agents Chemother. 1995 Apr;39(4):906-9. doi: 10.1128/AAC.39.4.906.
6
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Antimicrob Agents Chemother. 1995 Jan;39(1):40-4. doi: 10.1128/AAC.39.1.40.
7
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
J Clin Microbiol. 1995 May;33(5):1104-7. doi: 10.1128/jcm.33.5.1104-1107.1995.
Zotero 插件